Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

European urology - 1 Jul 2003

Hessels Daphne, Klein Gunnewiek Jacqueline M T, van Oort Inge, Karthaus Herbert F M, van Leenders Geert J L, van Balken Bianca, Kiemeney Lambertus A, Witjes J Alfred, Schalken Jack A

Abstract excerpt

BACKGROUND: DD3(PCA3) is the most prostate cancer-specific gene described to date. To assess the clinical utility of DD3(PCA3) a time-resolved fluorescence-based, quantitative RT-PCR analysis for DD3(PCA3) was developed. METHODS: The diagnostic potential of DD3(PCA3) was determined by quantitative measurement of DD3(PCA3) transcripts in non-malignant and malignant prostate specimens. Moreover, DD3(PCA3)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy, Needle
Share to Predictive Value of Tests

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prostate-Specific Antigen

Share to Prostatectomy

Share to Prostatic Neoplasms

Share to Reference Values

Share to RNA, Neoplasm

Share to ROC Curve

Source

Identifiers

PMID: 12814669
DOI: 10.1016/s0302-2838(03)00201-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.PMID 12814669Read ↗

A sensitive and specific non-invasive urine biomarker panel for prostate cancer detectionSemantic proximity Read ↗

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.Semantic proximity Read ↗

Use of multiple biomarkers for a molecular diagnosis of prostate cancerSemantic proximity Read ↗

Genome-wide association study identifies genetic determinants of urine PCA3 levels in men.Semantic proximity Read ↗

Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies.Semantic proximity Read ↗

Molecular study of the PCA3 gene: genotypic analysis of PCA3 polymorphism -845G>A and metastatic prostate cancer.Semantic proximity Read ↗

Detection of TMPRSS2-ERG Fusion Transcripts and Prostate Cancer Antigen 3 in Urinary Sediments May Improve Diagnosis of Prostate CancerSemantic proximity Read ↗

Promoter polymorphisms of the PCA3 gene are not associated with its overexpression in prostate cancer patients.Semantic proximity Read ↗

Prostate-specific RNA aptamer: promising nucleic acid antibody-like cancer detectionSemantic proximity Read ↗

Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer.Semantic proximity Read ↗

PBX3 is a putative biomarker of aggressive prostate cancerSemantic proximity Read ↗

Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.